66
Participants
Start Date
October 31, 2008
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
99mTc-glucarate solution
Patients will receive a single 22 - 27 mCi bolus intravenous dose of 99mTc-glucarate solution, as soon as possible after their arrival in the emergency department or the chest pain center
University of Pittsburgh Medical Center, Pittsburgh
University of Alabama at Birmingham, Birmingham
University Hospital Case Medical Center, Cleveland
Yale University, New Haven
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Yale University
OTHER
University of Pittsburgh
OTHER
University of Alabama at Birmingham
OTHER
University Hospitals Cleveland Medical Center
OTHER
Molecular Targeting Technologies, Inc.
INDUSTRY